CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This trial is a Phase 2 neoadjuvant study evaluating ARV-471 or anastrozole in post-menopausal women with ER+/HER2- localized breast cancer...
Phase 2
Fort Lauderdale, Florida, United States and 48 other locations
The purpose of this study is to find out the possible anti-cancer effect of pelareorep in combination with chemotherapy [paclitaxel] and ave ...
Phase 2
Miami, Florida, United States and 17 other locations
A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...
Phase 2
Hollywood, Florida, United States and 57 other locations
to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...
Phase 3
Miami, Florida, United States and 114 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Plantation, Florida, United States and 324 other locations
human epidermal receptor 2-negative (HER2)- palbociclib-resistant breast cancer, and to determine the recommended Phase 2 dose (RP2...
Phase 1, Phase 2
Fort Lauderdale, Florida, United States and 5 other locations
postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...
Phase 2
Miami, Florida, United States and 50 other locations
The purpose of this study is to compare the effect of Eflapegrastim on duration of neutropenia in patients with early-stage breast cancer...
Phase 1
Plantation, Florida, United States of America and 7 other locations
Most physicians still use a one-size-fits-all approach to breast screening in which all women, regardless of their personal history, family ...
Miami, Florida, United States and 10 other locations
The purpose of this study is to evaluate the safety and tolerability of talectrectinib as treatment for Stage IV ILC with CDH1 mutation
Phase 2
Weston, Florida, United States and 1 other location
Clinical trials
Research sites
Resources
Legal